Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Health crawled time : 14:02 save search
Turning Point Therapeutics Granted FDA Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer Who Have Not Been Treated with a ROS1 Tyrosine Kinase Inhibitor
Published: 2020-12-08 (Crawled : 14:02) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: 4.68%
H: 4.34%
C: 3.86%
cancer therapy positive fda lung cancer breakthrough therapy tyrosine kinase inhibitor designation
Cerner and Elligo to Make Clinical Trials Accessible for Health Systems of All Sizes
Published: 2020-12-08 (Crawled : 14:02) - globenewswire.com
CERN | $94.92 0.03%
|
Technology Services
|
| O: -0.95%
H: 2.83%
C: 2.77%
trial health
BridgeBio Pharma and Maze Therapeutics Establish Joint Venture to Advance Precision Medicine to Treat Cardiovascular Disease
Published: 2020-12-07 (Crawled : 14:02) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.29%
H: 2.37%
C: 1.45%
disease cardio cardiovascular pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.